Literature DB >> 128356

The effects of ammonium, inorganic phosphate and potassium ions on the activity of phosphofructokinases from muscle and nervous tissues of vertebrates and invertebrates.

P H Sugden, E A Newsholme.   

Abstract

1. The effect of NH4+, Pi and K+ on phosphofructokinase from muscle and nervous tissues of a large number of animals was investigated. The activation of the enzyme from lobster abdominal muscle by NH4+ was increased synergistically by the presence of Pi or SO4(2-). In the absence of K+, NH4+ plus Pi markedly activated phosphofructokinase from all tissues studied. In the presence of 100 mM-K+, NH4+ plus Pi activated phosphofructokinase from nervous tissue and muscle of invertebrates and the enzyme from brain of vertebrates, but there was no effect of NH4+ plus Pi on the enzyme from the muscles of vertebrates. Nonetheless, NH4+ plus Pi increased the activity of vertebrate muscle phosphofructokinase in the presence of 50 mM-K+ at inhibitory concentrations of ATP, i.e. these ions de-inhibited the enzyme. In the absence of NH4+ plus Pi, K+ activated phosphofructokinase from vertebrate tissues at non-inhibitory ATP concentrations, but the effect was less marked with the enzyme from invertebrate tissues. Indeed, high concentrations of K+ (greater than 50 mM) caused inhibition of invertebrate tissue phosphofructokinase. Of the other alkali-metal ions tested, only Rb+ activated phosphofructokinase from lobster abdominal muscle and rat heart muscle. 2. The properties of lobster abdominal-muscle phosphofructokinase were studied in detail. This muscle was chosen as representative of invertebrate muscle because large quantities of tissue could be obtained from one animal and the enzyme was considerably more stable in tissue extracts than in extracts of insect flight muscle. In general, the properties of the enzyme from this tissue were similar to those of the enzyme from many other tissues: ATP concentrations above an optimum value inhibited the enzyme and this inhibition was decreased by raising the fructose 6-phosphate or the AMP concentration. In particular, NH4+ plus Pi activated the enzyme at noninhibitory concentrations of ATP and they also relieved ATP inhibition (see above). 3. It is suggested that increases in the concentration of NH4+ and Pi, under conditions of increased ATP utilization in certain muscles and/or nervous tissue, may play a part in the stimulation of glycolysis through the effects on phosphofructokinase (the effect may be a direct activation and/or a relief of ATP inhibition). Changes in the concentration of NH4+ and Pi are consistent with this theory in nervous tissue and the anaerobic type of muscles. The role of AMP deaminase in production of NH4+ from AMP in these tissues is discussed in relation to the control of glycolysis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 128356      PMCID: PMC1165710          DOI: 10.1042/bj1500113

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN.

Authors:  O H LOWRY; J V PASSONNEAU; F X HASSELBERGER; D W SCHULZ
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

2.  Preparation of 5'-adenylic acid deaminase based on phosphate-induced dissociation of rat actomyosin-deaminase complexes.

Authors:  R D CURRIE; H L WEBSTER
Journal:  Biochim Biophys Acta       Date:  1962-10-08

3.  Partial purification and some properties of brain phosphofructokinase.

Authors:  J A MUNTZ
Journal:  Arch Biochem Biophys       Date:  1953-02       Impact factor: 4.013

4.  The formation of ammonia in brain extracts.

Authors:  J A MUNTZ
Journal:  J Biol Chem       Date:  1953-03       Impact factor: 5.157

5.  Regulation of metabolism in working muscle in vivo. II. Concentrations of adenine nucleotides, arginine phosphate, and inorganic phosphate in insect flight muscle during flight.

Authors:  B Sacktor; E C Hurlbut
Journal:  J Biol Chem       Date:  1966-02-10       Impact factor: 5.157

6.  Muscle AMP aminohydrolase. 3. A comparative study on the regulatory properties of skeletal muscle enzyme from various species.

Authors:  S Ronca-Testoni; A Raggi; G Ronca
Journal:  Biochim Biophys Acta       Date:  1970-01-14

7.  Glycogen, ammonia and related metabolities in the brain during seizures evoked by methionine sulphoximine.

Authors:  J Folbergrová; J V Passonneau; O H Lowry; D W Schulz
Journal:  J Neurochem       Date:  1969-02       Impact factor: 5.372

8.  Regulation of glucose uptake by muscles. 10. Effects of alloxan-diabetes, starvation, hypophysectomy and adrenalectomy, and of fatty acids, ketone bodies and pyruvate, on the glycerol output and concentrations of free fatty acids, long-chain fatty acyl-coenzyme A, glycerol phosphate and citrate-cycle intermediates in rat heart and diaphragm muscles.

Authors:  P B Garland; P J Randle
Journal:  Biochem J       Date:  1964-12       Impact factor: 3.857

9.  PROPERTIES OF PHOSPHOFRUCTOKINASE FROM RAT LIVER AND THEIR RELATION TO THE CONTROL OF GLYCOLYSIS AND GLUCONEOGENESIS.

Authors:  A H UNDERWOOD; E A NEWSHOLME
Journal:  Biochem J       Date:  1965-06       Impact factor: 3.857

10.  FRUCTOSE 1, 6-DIPHOSPHATASE IN STRIATED MUSCLE.

Authors:  H A KREBS; M WOODFORD
Journal:  Biochem J       Date:  1965-02       Impact factor: 3.857

View more
  26 in total

1.  Energy metabolism of synaptosomal subpopulations from different neuronal systems of rat hippocampus: effect of L-acetylcarnitine administration in vivo.

Authors:  A Gorini; A D'Angelo; R F Villa
Journal:  Neurochem Res       Date:  1999-05       Impact factor: 3.996

2.  The maximum activities of hexokinase, phosphorylase, phosphofructokinase, glycerol phosphate dehydrogenases, lactate dehydrogenase, octopine dehydrogenase, phosphoenolpyruvate carboxykinase, nucleoside diphosphatekinase, glutamate-oxaloacetate transaminase and arginine kinase in relation to carbohydrate utilization in muscles from marine invertebrates.

Authors:  V A Zammit; E A Newsholme
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

3.  Effects of simulated upper gastrointestinal hemorrhage on ammonia and related amino acids in blood and brain of chronic portacaval-shunted rats.

Authors:  S W Olde Damink; C H Dejong; N E Deutz; P B Soeters
Journal:  Metab Brain Dis       Date:  1997-06       Impact factor: 3.584

4.  Phenobarbital and 6-aminonicotinamide effect on cerebral enzymatic activities related to energy metabolism in different rat brain areas.

Authors:  F Marzatico; F Dagani; D Curti; G Benzi
Journal:  Neurochem Res       Date:  1987-01       Impact factor: 3.996

5.  Peak blood ammonia and lactate after submaximal, maximal and supramaximal exercise in sprinters and long-distance runners.

Authors:  H Itoh; T Ohkuwa
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

6.  Modifications by chronic intermittent hypoxia and drug treatment on skeletal muscle metabolism.

Authors:  O Pastoris; M Dossena; P Foppa; R Arnaboldi; A Gorini; R F Villa; G Benzi
Journal:  Neurochem Res       Date:  1995-02       Impact factor: 3.996

7.  Influence of intermittent hypoxia and pyrimidinic nucleosides on cerebral enzymatic activities related to energy transduction.

Authors:  F Dagani; F Marzatico; D Curti; M Taglietti; F Zanada; G Benzi
Journal:  Neurochem Res       Date:  1984-08       Impact factor: 3.996

8.  Parkinson-like disease by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in Macaca fascicularis: synaptosomal metabolism and action of dihydroergocriptine.

Authors:  R F Villa; R Arnaboldi; B Ghigini; A Gorini
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

9.  Changes induced by ischemia on some cerebral enzymatic activities related to energy transduction and amino acid metabolism.

Authors:  R F Villa; F Marzatico; G Benzi
Journal:  Neurochem Res       Date:  1983-02       Impact factor: 3.996

Review 10.  Effects of hyperammonaemia on brain function.

Authors:  R F Butterworth
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.